The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Castration resistance and risk of bone metastases among men with nonmetastatic prostate cancer on androgen-deprivation therapy: A population-based cohort study from the Henry Ford Health System (HFHS) in Detroit, Michigan.
Jennifer Beebe-Dimmer
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Karynsa Cetin
Employment or Leadership Position - Amgen
Cecilia Yee
No relevant relationships to disclose
Scott Stryker
Employment or Leadership Position - Amgen
Lois Lamerato
No relevant relationships to disclose
Kendra L. Schwartz
No relevant relationships to disclose
Vahakn B. Shahinian
Consultant or Advisory Role - Amgen